Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for COVID-19

• Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19
• Immunogenicity After COVID-19 Vaccines in Adapted Schedules
• Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease
• Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
• Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment
• A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
• Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
• Amantadine Therapy for Cognitive Impairment in Long COVID
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
• A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
• A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
• Study of Obeldesivir in Children and Adolescents With COVID-19
• Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
• Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
• A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients
• Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
• An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
• Probiotic and Colchicine in COVID-19
• Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19
• Cupping Therapy on Immune System in Post Covid -19
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
• Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19
• Pycnogenol® in Post-COVID-19 Condition
• Evaluating Emetine for Viral Outbreaks (EVOLVE)
• Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
• A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.
• Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
• Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study
• Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI
• Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19
• REVERSE-Long COVID-19 With Baricitinib Pilot Study
• The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
• Arginine Replacement Therapy in COVID-19
• PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
• Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention
• The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants
• imPROving Quality of LIFe In the Long COVID Patient
• Postoperative Sugammadex After COVID-19
• A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
• Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19
• Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities
• Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 )
• A Nasal Treatment for COVID-19
• A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized.
• Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia
• Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
• Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
• RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19
• Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
• Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19
• LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19
• PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
• MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
• Study of HS-10517 in Chinese Adult Participants
• Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients
• Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.
• Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients
• A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2
• Oxygen Atomizing Inhalation of EGCG in the Treatment COVID-19 Pneumonia in Cancer Patients
• A Phase 3 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
• Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection
• A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19
• AT1001 for the Treatment of Long COVID
• Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivmermectin 400)
• To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
• Study of Monoclonal Antibodies for Early Etiotropic Therapy for Coronavirus Infection Caused by the SARS-CoV-2 Virus
• Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
• MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance
• Inhaled NO in Surgical Patients With Recent COVID-19 Infection
• Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
• Study to Access the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
• Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
• Study Evaluating GS-5245 in Nonhospitalized Participants With COVID-19
• A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
• Pirfenidone in Adult Hospitalized Patients With COVID-19
• Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection
• Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
• Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care
• A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
• Tetrandrine Tablets Used in Hospitalized Adults With COVID-19
• Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19
• Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients.
• Safety and Efficacy of the Therapy With BREINMAX® for the Treatment of Patients With Asthenia After COVID-19
• Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
• A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
• Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
• Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China
• UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
• A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants
• Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19
• Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
• Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumoia
• Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
• Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People
• Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
• The Application of Ursodeoxycholic Acid for the Prevention of Novel Coronavirus Infections
• The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2
• Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients
• 101-PGC-005 for the Treatment of COVID-19
• Comparative Study of the Efficacy and Safety of Ambervin and Standard Therapy in Hospitalized Patients With COVID-19
• Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
• Post-COVID-19 Chronic Fatigue Syndrome
• The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
• COVID-19 Huashi Baidu Formula Clinical Study
• Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
• Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
• Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19
• Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
• SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
• Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate SARS-CoV-2 Infection
• A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
• A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster
• Study Evaluating GS-5245 in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
• A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster
• Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population
• Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19
• Safety and Efficacy of Medications COVID-19
• Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients
• Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19
• International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
• OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
• A Study of FB2001 for Inhalation in Healthy Chinese Adults
• JT001 (VV116) for the Treatment of COVID-19
• A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
• Multicenter, Double-blind, Randomized, Placebo-controlled Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia
• PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
• The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
• PBI-0451 Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
• Evaluation of the Efficacy of Mouth Rinses With Commercial Mouthwashes to Decrease Viral Load in Saliva in COVID-19 Patients
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
• Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study
• Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Moderate or Severe COVID-19
• Efficacy and Safety of ES16001 in Patients With COVID-19
• Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects
• Phase 2 Study of the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
• Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects
• Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19
• Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.
• Canadian Adaptive Platform Trial for Long COVID
• Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection
• A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
• A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
• Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients
• Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019
• Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome
• A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
• rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
• A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
• SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW
• Beta-glucans for Hospitalised Patients With COVID-19
• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
• Intranasal Insulin for COVID-19-related Smell Loss
• A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care
• Mineralocorticoid Use in COVID-19 Patients
• NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus D
• Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I
• Topical Antibacterial Agents for Prevention of COVID-19
• Value of Montelukast as a Potential Treatment of Post COVID-19 Persistent Cough
• Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus
• Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)
• Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
• Study to Verify the Effectiveness and Safety of the Modified Isothymol or Carvacrol Compound Against SARS-CoV-2
• A Randomized, Single-Center, Single-Blind, Placebo Controlled, Investigator Initiated Trial to Evaluate the Efficacy of PanCytoVir™ 500 mg Twice Daily and 1000 mg Twice Daily for the Treatment of Non-Hospitalized Patients With COVID-19 Infection
• Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients
• A Study to Learn About the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With COVID-19 Who Are Immunocompromised
• Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults
• A Phase 1b Study of a Q-Griffithsin Intranasal Spray for Broad-spectrum Coronavirus Prophylaxis
• Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)
• ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)
• IMM-BCP-01 in Mild to Moderate COVID-19
• Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
• Calcitriol Supplementation in COVID-19 Patients
• COVID-19 Algorithm Treatment at Home
• Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
• Inhibition of Bradykinin in COVID-19 Infection With Icatibant
• Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)
• Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
• Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19
• A Study to Learn About the Study Medicine (Called Nirmatrelvir/Ritonavir) in Pregnant Women With Mild or Moderate COVID-19.
• Paxlovid in the Treatment of COVID-19 Patients With Uremia
• A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.
• Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children
• Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Placebo-Controlled, Phase II Clinical Study
• To Evaluate SSD8432/Ritonavir in Adults With COVID-19
• Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents
• Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine
• Endothelial Protection in Post COVID-19 Patients With Sulodexide
• Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation
• To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
• A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins (ORFEUS)
• Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)
• Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
• Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers
• Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
• The Use of Chinese Herbal Medicine and Vitamin C by Hospital Care Workers in HK to Prevent COVID-19
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
• A Study of COVID-19 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
• A Study of COVID-19 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.
• Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
• To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.
• A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19
• Efficacy and Safety of JT001 (VV116) Compared With Paxlovid
• Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
• Non-inferiority Trial on Treatments in Early COVID-19
• Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
• Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
• A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
• A Study to Compare S-217622 With Placebo in Non-Hospitalized High-Risk Participants With COVID-19
• Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19.
• Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19
• Paediatric VLA2001-321 Study
• Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody(Ies) in Adult Healthy Volunteers as Related to COVID
• ApTOLL for the Treatment of COVID-19
• Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2
• COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)
• Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea
• Phase I/II, Open-label Dose-Escalation Randomized Study of High-Dose mRNA-1273 Booster for Lung Transplant Recipients
• Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
• Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome
• Efficacy and Safety of JT001 (VV116) Compared With Favipiravir
• STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
• Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19
• Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment
• Add-on Study on Solidarity Trial Plus in Nepal
• Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2
• Inhalational Ethanol Therapy (Spray and Nebulized ETHO) in COVID-19 Treatment
• An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19
• EPIC-Peds: Study of Oral PF-07321332 (Nirmatrelvir)/Ritonavir in Nonhospitalized COVID-19 Pediatric Patients at Risk for Severe Disease
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• Nebulised Heparin in Patients With COVID-19 Pneumonia
• Reparixin as add-on Therapy to Standard of Care to Limit Disease Progression in Adult Patients With COVID-19.
• Endothelial Protection in Convalescent COVID-19 Patients
• Phase 3 Study to Evaluate a Single Booster of the NVX-CoV2373 COVID19 Vaccine in Adults
• Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment
• A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule as a Combination Regimen With Standard Treatment for Patients With Mild to Moderate COVID-19
• A Study of EDP-235 in Healthy Subjects
• Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients
• JT001 (VV116) for the Early Treatment of COVID-19
• Assessing the Safety and Efficacy of MYMD1 to Treat Depression in Patients With Post-Acute Sequelae of Coronavirus Disease-2019 (PASC)
• Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
• BetaShield: A Phase II, Randomized Trial to Test the Effect of Povidone-iodine 0.5% as Mouthwash/Gargle on SARS-CoV-2 Load (COVID 19) as an Adjuvant Infection Control Measure in Dental Practice
• Study in Healthy Subjects and Symptomatic Covid-19 Positive Patients to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of the Novel Self-administered Intranasal CG- SpikeDown Antiviral Drug
• Ivermectin for Post Exposure Prophylaxis of Covid-19
• Zofin to Treat COVID-19 Long Haulers
• Safety and Efficacy of COVIDEX™ Therapy in Management of Adult COVID-19 Patients in Uganda.
• Study Design of the Diacerein in Patients With Covid-19
• Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19
• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
• Treatment of Non-Severe COVID-19 Outpatients With Xagrotin, Phase 3
• Nebulised BromAc in Healthy Volunteers
• SOLIDARITY Finland Plus Long COVID-19
• Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients With Moderate COVID-19
• Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
• Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia
• Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients
• Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19
• The Efficacy of Oral Antiseptics Against SARS-CoV-2
• Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults
• Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
• A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms
• A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals
• The siCoV/KK46 Drug Open-safety Study
• Non-inferiority Trial on Monoclonal Antibodies in COVID-19
• Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children
• A Bridging Study of FB2001 in Healthy Subjects
• Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources
• A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care
• The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19
• Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID in Healthy Adult Volunteers
• Randomized Study of Efficacy of Different Treatment Regimens of Olokizumab
• Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
• Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19
• Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19
• Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction
• Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19
• Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults
• GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)
• Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies
• A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
• COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers
• Phase 1 Clinical Trial of a Q GRFT Nasal Spray
• Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients
• Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
• Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
• A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
• Brequinar Combined With Dipyridamole in Patients With Mild to Moderate SARS-CoV-2 Infection.
• Severity of COVID-19 and Vitamin D Supplementation
• Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19
• A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
• Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
• Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail
• Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness
• Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness
• Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease
• Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial
• A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19
• A Double-blind Randomized Controlled Trial of Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients
• Efficacy, Safety, Tolerability of AXA1125 in Fatigue Predominant PASC
• Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection
• COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
• Association Between Administration of Systemic Corticosteroids and the Recovery of Olfactory and/or Gustatory Functions in Patients With COVID-19: A Prospective Cohort Study
• An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
• Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19
• Usefulness of DORNASE in COVID-19 on HFNO
• SP16 as a Therapeutic for SARS-CoV-2 Induced ARDS
• Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
• High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
• Nutritional Supplementation of Vitamin D, Quercetin and Curcumin With Standard of Care for Managing Mild Early Symptoms of COVID-19
• The South Proxa-Rescue AndroCoV Trial Against COVID-19
• Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial
• AV-001 for Hospitalized Patients With COVID-19 Disease
• PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray
• Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19
• Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
• Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
• Extension Study in a Cohort of Adult Patients With COVID-19 Infection
• Intranasal INNA-051 for Prevention of COVID-19 in Adults
• Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.
• The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
• the Safety and Efficacy of Meplazumab in Patients With COVID-19
• The Danish Pre-HCQ COVID Dialysis Study
• Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
• Homeopathic Treatment of Post-acute COVID-19 Syndrome
• Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
• PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
• Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
• Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19
• COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19
• JINZHEN for Treatment of Mild to Moderate COVID-19
• TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
• Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection
• Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
• Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community
• Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
• The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
• Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
• Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care
• Tocilizumab Versus Baricitinib in Patients With Severe COVID-19
• COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)
• Convalescent Plasma Therapy for Hospitalized Patients With COVID-19
• Cromolyn Sodium for Treatment of COVID-19 Pneumonia
• LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
• Efficacy of Ivermectin in COVID-19
• A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients
• Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.
• A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
• A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS)
• Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
• NAC for Attenuation of COVID-19 Symptomatology
• Acetylsalicylic Acid in COVID-19 (ASA-SARS)
• Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2
• A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19
• Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）
• RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow
• Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
• "Efesovir" (FS-1) for COVID-19, Phase 2
• Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]
• Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia
• A Phase III Confirmatory Study of K-237
• Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
• Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients
• FLuticasone in cOvid Treatment (FLOT)
• Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
• Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19
• Vortioxetine for Post-Covid-19 Syndrome
• Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
• A Post-Exposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19
• Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
• Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Mild-to-moderate COVID-19
• Combined Antihistaminics Therapy in COVID 19 Patients
• Prevention and Treatment of Patient Before, During, and After Covid-19 Infection
• Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
• COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor EP-7041 in ICU Patients
• Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19
• Phase 2a MIB-626 vs. Placebo COVID-19
• Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
• COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation
• Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
• A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
• A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
• Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
• High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial.
• Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.
• Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
• Public Health Emergency: SOLIDARITY TRIAL Philippines
• AT1001 for the Treatment of COVID-19 Related MIS-C
• Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19
• Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
• A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients
• To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects
• Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
• Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19
• Study of PBI-0451 in Healthy Subjects.
• A Study of PF-07321332/Ritonavir in Non-hospitalized Low-Risk Adult Participants With COVID-19
• Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study).
• A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects
• Efficacy of PJS-539 for Adult Patients With COVID-19.
• Dietary Supplements Vit D, Quercetin and Curcumin Combination for Early Symptoms of COVID-19
• Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
• Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
• Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.
• COVID-19 Methylene Blue Antiviral Treatment
• A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects
• Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
• Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.
• Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab
• Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
• Clinical Study to Assess the Antiviral Properties of Echinaforce Reducing Oropharyngeal Concentration and Infectivity of SARS-CoV2
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19
• Feasibility of Cannabidiol for the Treatment of Long COVID
• COVID-19 Administration of Single-Dose Subcutaneous or Intramuscular Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
• Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster
• Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
• CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
• Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
• Nigelle 5CH in Prevention of Influanza
• Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease
• Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
• ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
• HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients
• Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population
• In-patient COVID-19 Study of Intranasal Foralumab
• Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment
• Echinacea Drug for Covid-19
• Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
• Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
• Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19
• SOLIDARITY Finland Long COVID-19
• Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection
• Third Dose of COVID-19 Vaccine in LTCF Residents
• Colloidal Silver, Treatment of COVID-19
• Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19
• A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
• Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19
• Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
• Study of Varespladib in Patients Hospitalized With Severe COVID-19
• A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection
• TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
• Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19
• Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
• Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
• Coenzyme Q10 as Treatment for Long Term COVID-19
• A Study of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID-19
• MANS-NRIZ Trial for COVID-19 Treatment : Extension Study
• Lipid Emulsion Infusion and COVID-19 Patients
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.
• Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease
• Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
• Efficacy of Amantadine Treatment in COVID-19 Patients
• Acupuncture Therapy for COVID-Related Olfactory Loss
• Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT
• Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
• Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
• Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.
• Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
• Phase 2 Study of RSLV-132 in Subjects With Long COVID
• Remdesivir- Ivermectin Combination Therapy in Severe Covid-19
• "CHANGE COVID-19 Severity"
• Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients
• The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients
• Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19
• Study to Assess the Efficacy and Safety of Favipiravir-HU
• A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19
• Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
• Chinese Herbal Formula for COVID-19
• Ivermectin Versus Standard Treatment in Mild COVID-19
• Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19
• Outpatient Liquid Aspirin (OLA)
• C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.
• Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
• Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19
• COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy
• IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.
• MP1032 Treatment in Patients With Moderate to Severe COVID-19
• Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19
• Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)
• Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
• Study of Codivir in Patients With COVID-19
• Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination
• Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
• Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19
• InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
• In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection
• Chinese Medicine for Patients With LCOVID-19 Symptoms
• Novel Experimental COVID-19 Therapies Affecting Host Response
• A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Infliximab in the Treatment of Patients With Severe COVID-19 Disease
• Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19
• Ivermectin Treatment Efficacy in Covid-19 High Risk Patients
• Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
• Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
• Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19
• Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment
• Nigella 5 in the Treatment of SARS COV2 (COVID-19)
• To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants
• Safety and Effectiveness of an Immunobiological Drug in CoViD-19
• Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
• Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19
• Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19
• Impact of Steroids on Inflammatory Response in Covid-19
• Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress
• Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress
• Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19
• Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
• Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
• Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs
• Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
• Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction
• Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.
• Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
• Antithrombin III in Infectious Disease Caused by COVID-19
• Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)
• Amantadine for COVID-19
• A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2
• An Open-Label Study of Apabetalone in Covid Infection
• First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
• The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19
• Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
• A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients
• Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19
• Ivermectina Colombia (IVERCOL)
• ACTIV-6: COVID-19 Study of Repurposed Medications
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH
• The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
• Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19
• Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
• The Effect of Vitamin D Supplementation on COVID-19 Recovery
• Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients
• A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia
• A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
• A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
• A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
• Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
• Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints
• The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19)
• Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.
• Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
• Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore
• PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
• Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)
• Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.
• A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients
• Convalescent Plasma Therapy - Zurich Protocol
• Effectiveness of Colchicine Among Patients With COVID-19 Infection
• SARS-CoV-2 Human Challenge Characterisation Study
• Estradiol and Progesterone in Hospitalized COVID-19 Patients
• Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products
• Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home
• Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose
• Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS
• Hydroxychloroquine for Treatment of Non-Severe COVID-19
• Evaluation of ADG20 for the Prevention of COVID-19
• First-in-Human Study of Orally Administered GS-441524 for COVID-19
• Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
• A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection
• Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
• Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
• Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.
• The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms
• Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients
• Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
• Remdesivir Efficacy In Management Of COVID-19 Patients
• Olfactory Disfunction and Co-ultraPEALut
• Proxalutamide Treatment for COVID-19 Female Outpatients
• Oestrogen Treatment for COVID-19 Symptoms
• The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
• Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients
• Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
• A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients
• A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.
• Assessment of Efficacy of KAN-JANG® in Mild COVID-19
• Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
• The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
• A Clinical Study Evaluating Inhaled Aviptadil on COVID-19
• SLV213 Treatment in COVID-19 Patients
• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
• Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.
• Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome
• Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
• PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT)
• Nebulized Heparin for COVID19-associated Acute Respiratory Failure
• Cetirizine and Famotidine for COVID-19
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)
• Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
• Omega-3 Oil Use in COVID-19 Patients in Qatar
• Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
• Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients
• Randomized Open Investigation Determining Steroid Dose
• TCB008 in Patients With COVID-19
• Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
• Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
• Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
• Dasatinib for the Treatment of Moderate and Severe COVID-19
• Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes
• Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19
• A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
• Dual MRI for Cardiopulmonary COVID-19 Long Haulers
• Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)
• Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections
• The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
• A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19
• Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
• Colchicine and Post-COVID-19 Pulmonary Fibrosis
• Favipiravir in High-risk COVID-19 Patients
• Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
• STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
• Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes
• Essential Amino Acid Supplementation in Older Adult COVID-19 Patients
• Imaging Immune Activation in COVID-19
• Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH
• Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)
• Efficacy of Psidii Guava's Extract For COVID-19
• Pilot Trial of XFBD, a TCM, in Persons With COVID-19
• A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19
• Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID)
• Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19
• ANTIcoagulation in Severe COVID-19 Patients
• Urine Alkalinisation in COVID-19
• Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19
• Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
• Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
• HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)
• Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection
• Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19
• A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
• Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2)
• The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
• Corticosteroids for COVID-19
• Reparixin in COVID-19 Pneumonia - Efficacy and Safety
• Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
• Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
• Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
• Smell in Covid-19 and Efficacy of Nasal Theophylline
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts
• A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
• A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
• SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults
• Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
• Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection
• Ivermectin Reproposing for Mild Stage COVID-19 Outpatients
• Clinical Study in the Treatment of Patients With COVID-19
• JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
• TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic
• Dietary Supplements for COVID-19
• Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19
• Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt
• COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications
• Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19
• A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19
• A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
• Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic
• Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients
• Honey and Nigella Sativa in COVID-19 Prophylaxis
• The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection
• Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection
• Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19
• Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
• Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19
• Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19
• COVID-19 Antithrombotic Rivaroxaban Evaluation
• Impact of Colchicine and Low-dose Naltrexone on COVID-19
• Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management
• Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia
• Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat
• Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia
• A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
• Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators
• Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
• Treatment of Nosocomial COVID-19
• Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection
• COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study
• Ivermectin Role in Covid-19 Clinical Trial
• Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19
• AGILE (Early Phase Platform Trial for COVID-19)
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
• Enriched Heparin Anti COVID-19 Trial
• A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
• Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
• Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19
• Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia
• Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
• A First-in-Human Study of AV-001 in Healthy Subjects
• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
• Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms
• A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
• Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19
• The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19
• COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA
• Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection
• The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients
• Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.
• Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)
• Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
• TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
• The DAWN Camostat Trial for Ambulatory COVID-19 Patients
• Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.
• EAT-DUTA AndroCoV Trial
• An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization
• Proxalutamide Treatment for Hospitalized COVID-19 Patients
• Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress
• Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms
• Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
• Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome
• Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
• Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)
• Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19
• Nebulized Heparin for the Treatment of COVID-19
• Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
• Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva
• Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
• A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
• The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load
• Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients
• Investigation the Effect of Montelukast in COVID-19
• Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19
• APT™ T3X on the COVID-19 Contamination Rate
• Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
• INvestigating TELmisartin Study
• Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy
• Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19
• Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
• Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
• The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)
• Fluvoxamine for Adults With Mild to Moderate COVID-19
• IMUNOR® Preparation in the Prevention of COVID-19
• Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
• Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
• To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
• Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia
• Tolerability and Efficacy of RJX in Patients With COVID-19
• Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19
• A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
• Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients
• Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
• Sargramostim Use in COVID-19 to Recover Patient Health
• Dexamethasone for COVID-19
• Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)
• Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection
• Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
• Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
• Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan
• A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19)
• The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients
• Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
• Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
• The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers
• Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:
• Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
• Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
• Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients
• A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
• Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
• Synthetic CBD as a Therapy for COVID-19
• Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home
• Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
• A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19
• Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
• Inhaled Ivermectin and COVID-19
• suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
• Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers
• Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia
• Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia
• COVID-19 Long-Haulers Study
• Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
• Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia
• Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
• Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
• Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19
• A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19
• Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment
• Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients
• Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
• Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults
• Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)
• Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
• Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
• Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents
• Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)
• Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19
• Mushroom-based Product for COVID-19
• COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
• Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
• Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)
• Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19
• Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
• Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol
• Fenofibrate for Patients With COVID-19 Requiring Hospitalization
• A Study of Auxora in Patients With Critical COVID-19 Pneumonia
• Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
• Evaluation of Aerosol in a Dental Clinic
• A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Hyperpolarized 129Xe MRI of Survivors of COVID-19
• Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19
• A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)
• Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease
• At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
• Urine Alkalinisation to Prevent AKI in COVID-19
• Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
• Treatment With Pirfenidone for COVID-19 Related Severe ARDS
• Camostat With Bicalutamide for COVID-19
• Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
• LYT-100 in Post-acute COVID-19 Respiratory Disease
• Defibrotide for the Treatment of Severe COVID-19
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
• Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
• IFN-beta 1b and Remdesivir for COVID19
• World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments
• Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -
• Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19
• MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
• Ivermectin for Severe COVID-19 Management
• A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19
• Effects of Fuzheng Huayu Tablets on COVID-19
• The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19
• Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
• Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
• Anakinra in the Management of COVID-19 Infection
• A Phase II/III Study of Sargramostim
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
• Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
• Contrast Enhanced Ultrasound in COVID-19
• A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19
• A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
• Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
• Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection
• Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
• Methylene Blue Treatment of COVID-19
• Inhaled Heparin for Hospitalised COVID-19 Patients
• Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
• Hydrogen Therapy in Patients With Moderate Covid-19
• Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19
• BCG Vaccination to Prevent COVID-19
• Intravenous Zotatifin in Adults With Mild or Moderate COVID-19
• SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation
• Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC
• Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
• A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
• CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)
• Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
• Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
• Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.
• Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
• Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
• The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden
• Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?
• Randomised Study of Plasma Exchange in Severe COVID-19
• A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
• Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection
• Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
• Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
• An Outpatient Study Investigating Non-prescription Treatments for COVID-19
• Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
• Outpatient Treatment With CoVid-19 With Prexablu
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia
• IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
• Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
• Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
• REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study
• Mesenchymal Stem Cells in Patients Diagnosed With COVID-19
• Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2
• Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)
• REMdesivir-HU Clinical Study and Severe Covid-19 Patients
• Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants
• Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
• CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients
• Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
• Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
• Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
• Treat COVID-19 Patients With Regadenoson
• Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
• A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
• Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
• Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19
• Comparison of Two Different Doses of Bemiparin in COVID-19
• Effect of Pioglitazone on T2DM Patients With COVID-19
• ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
• Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients
• Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19
• Anakinra, COVID-19, Cytokine Storm
• Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
• Study to Investigate the Benefits of Colchicine in Patients With COVID-19
• Ivermectin in Adults With Severe COVID-19.
• Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia
• The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin
• Clinical Trial of Favipiravir Treatment of Patients With COVID-19
• The Prevent Severe COVID-19 (PRESECO) Study
• Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients
• Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis
• Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)
• Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient
• Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
• Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients
• Immune Modulators for Treating COVID-19
• To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
• Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients
• The COVID-RASi Trial (COVID-19)
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
• Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
• Furosemide as Supportive Therapy for COVID-19 Respiratory Failure
• The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
• Study to Assess the Effect of Meplazumab on COVID-19
• A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
• Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19
• Mouth Rinses for Inactivation of COVID-19
• OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
• ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
• ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19
• Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)
• Efficacy of Nicotine in Preventing COVID-19 Infection
• Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects
• An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.
• Inflammatory Signal Inhibitors for COVID-19 (MATIS)
• PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
• Fostamatinib for Hospitalized Adults With COVID-19
• Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)
• Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19
• COVID-19: Salvage TOcilizumab as a Rescue Measure
• Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19
• Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19
• Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers
• IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
• HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
• An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
• CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
• A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure
• Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
• Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
• Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients
• Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)
• Ravulizumab and COVID-19
• Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19
• GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia
• Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
• Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
• Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19
• Study of AZD1222 for the Prevention of COVID-19 in Japan
• Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)
• Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19
• Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)
• Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients
• Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19
• Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
• Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia
• Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers
• COVID-19 Prophylaxis South Africa (COVER HCW)
• Tocilizumab in COVID-19 Lahore General Hospital
• Methylprednisolone in COVID-19 Patients (Methyl19LGH)
• Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic
• The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19
• A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19
• A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19
• A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
• New Treatment for COVID-19 Using Ethanol Vapor Inhalation .
• Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)
• Effect of Vitamin D on Morbidity and Mortality of the COVID-19
• Effects of Early Use of Nitazoxanide in Patients With COVID-19
• Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
• Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis
• Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
• Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19
• Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure
• Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19
• Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo
• Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
• A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
• Nebulised Heparin in Patients With Severe COVID-19
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients
• Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19
• Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
• Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
• To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.
• Niclosamide in COVID-19
• Hamburg Edoxaban for Anticoagulation in COVID-19 Study
• Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19
• Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19
• Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis
• To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
• Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia
• NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
• A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
• Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
• COVID-19 Study of Safety and Tolerability of Alvelestat
• Estrogen Therapy in Non-severe COVID-19 Patients
• COVID-19 (VA CURES-1)
• Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
• A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
• Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
• COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7
• COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
• Cri Analog PG1 Effectiveness and Safety in Covid-19
• Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
• Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
• Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
• Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
• Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
• Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
• First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
• BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)
• COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;
• Pegylated Interferon Lambda for Treatment of COVID-19 Infection
• Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19
• Tafenoquine in Patients With Mild to Moderate COVID-19
• COVID-19 Treatment in South Africa
• Growth Hormone in Obese Cases With Covid-19
• Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
• Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
• Selective Estrogen Modulation and Melatonin in Early COVID-19
• Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients
• Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
• Outpatient Use of Ivermectin in COVID-19
• Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
• Timing of Corticosteroids in COVID-19
• Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• Ivermectin to Prevent Hospitalizations in COVID-19
• Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients
• Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
• S-Nitrosylation Therapy of COVID-19
• Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19
• Anosmia and / or Ageusia and Early Corticosteroid Use
• Colchicine in Moderate Symptomatic COVID-19 Patients
• Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
• Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia
• Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia
• Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
• An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19
• Lactoferrin for Prevention of COVID-19 in Health Care Workers
• Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
• To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
• Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients
• Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
• Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
• Catalysing the Containment of COVID-19
• A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
• Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
• the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19
• Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
• Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19
• CSL324 in COVID-19
• Toclizumam Versus Dexamethasone in Severe Covid-19 Cases
• Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
• ACTIV-2: A Study for Outpatients With COVID-19
• Halodine Nasal Antiseptic in Patients With COVID-19
• Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
• CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
• IMU-838 and Oseltamivir in the Treatment of COVID-19
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)
• AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19
• A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects
• Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19
• Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
• Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
• FREEDOM COVID-19 Anticoagulation Strategy
• Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
• Losmapimod Safety and Efficacy in COVID-19
• A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
• Telmisartan in Respiratory Failure Due to COVID-19
• Canakinumab in Patients With COVID-19 and Type 2 Diabetes
• Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects
• Ivermectin Nasal Spray for COVID19 Patients
• COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
• Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury
• Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection
• Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia
• Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
• A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
• Tenecteplase in Patients With COVID-19
• Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19
• Bucillamine in Treatment of Patients With COVID-19
• Role of Famotidine in the Clinical Improvement of COVID-19 Patients.
• A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
• Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19
• Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
• ACTIV-3: Therapeutics for Inpatients With COVID-19
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
• A Trial of NT-I7 in COVID-19 (SPESELPIS)
• Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
• Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients
• Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients
• To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
• Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
• FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals
• Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
• Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)
• COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
• A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff
• Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19
• Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients
• Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers
• Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85
• COVID-19 Anosmia Study
• Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19
• A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
• Clazakizumab vs. Placebo - COVID-19 Infection
• BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
• IFN Beta-1b and Ribavirin for Covid-19
• Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19
• Cyclosporine For The Treatment Of COVID-19(+)
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
• Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
• Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center
• Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
• Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression
• Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.
• Intranasal Heparin Tolerability Study
• Sildenafil in COVID-19
• Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection
• I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
• CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
• A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19
• Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
• Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
• Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
• Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
• DISulfiram for COvid-19 (DISCO) Trial
• Corticosteroid Nasal Spray in COVID-19 Anosmia
• SPI-1005 Treatment in Moderate COVID-19 Patients
• SPI-1005 Treatment in Severe COVID-19 Patients
• Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial
• Suloexide in the Treatment of Early Stages of COVID-19
• Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
• Trial of Combination Therapy to Treat COVID-19 Infection
• Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
• Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial
• A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)
• The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.
• Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
• Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)
• Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198
• Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196
• Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
• The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
• SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
• Abatacept for Patients With COVID-19 and Respiratory Distress
• Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
• COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
• Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
• Enzalutamide Treatment in COVID-19
• Efficacy and Safety of Itolizumab in COVID-19 Complications
• Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
• The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
• Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
• COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
• Efficacy of Iodine Complex Against COVID-19 Patients
• Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19
• DEFINE - Evaluating Therapies for COVID-19
• Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients
• Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)
• Role of Co-trimoxazole in Severe COVID-19 Patients
• Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
• Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
• Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia
• REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
• To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients
• The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19
• Antiviral Agents Against COVID-19 Infection
• CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms
• Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
• Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
• Hemostasis in COVID-19: an Adaptive Clinical Trial
• Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
• Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
• Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
• Favipiravir Therapy in Adults With Mild COVID-19
• Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients
• Desidustat in the Management of COVID-19 Patients
• Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
• SCIL-1Ra in COVID-19 Feasibility & PK/PD
• Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers
• Efficacy and Safety of Sirolimus in COVID-19 Infection
• PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
• A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19
• Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia
• A Study of Combination Therapies to Treat COVID-19 Infection
• Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
• The Nitazoxanide Plus Atazanavir for COVID-19 Study
• Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients
• Convalescent Plasma in Pediatric COVID-19
• A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
• Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients
• Atovaquone for Treatment of COVID-19
• Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19
• Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year
• A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive.
• Inflammatory Regulation Effect of NAC on COVID-19 Treatment
• Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19
• Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients
• Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia
• Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
• VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
• NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
• Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
• Safety and Efficacy of C21 in Subjects With COVID-19
• COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-Co
• Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia
• Povidone-Iodine Rinses in the Management of COVID-19
• Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
• Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)
• Control of COVID-19 Outbreaks in Long Term Care
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
• DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
• Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
• Anti-Androgen Treatment for COVID-19
• A Study of LAM-002A for the Prevention of Progression of COVID-19
• A Preventive Treatment for Migrant Workers at High-risk of COVID-19
• Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers
• Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
• Prasugrel in Severe COVID-19 Pneumonia
• An Adaptive Clinical Trial of Antivirals for COVID-19 Infection
• Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
• Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
• Inhaled Iloprost for Suspected COVID-19 Respiratory Failure
• Mesenchymal Stem Cell Infusion for COVID-19 Infection
• Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
• Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
• Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients
• InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
• Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients
• Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).
• Universal Anti-Viral Vaccine for Healthy Elderly Adults
• Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
• Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
• Glucocorticoids in COVID-19 (CORTIVID)
• COVidIVERmectin: Ivermectin for Treatment of Covid-19
• Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers
• Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
• Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
• Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19
• Inhaled Ciclesonide for Outpatients With COVID19
• Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01)
• Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19
• Crizanlizumab for Treating COVID-19 Vasculopathy
• The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
• An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
• Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19
• A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19
• Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
• A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19
• Dornase Alpha for the Treatment of COVID-19
• A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients
• Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
• Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)
• Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease
• Donated Antibodies Working Against nCoV
• Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19
• Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS
• Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation.
• Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia
• Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure
• Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
• Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19
• A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
• Study of the Sars-Cov2 Neuroinvasiveness - COVID19
• Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients
• Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
• InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
• A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
• MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)
• Ivermectin In Treatment of COVID 19 Patients
• Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
• A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
• A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
• Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19
• BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
• A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease
• Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
• Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
• Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19
• A Study of Baricitinib (LY3009104) in Participants With COVID-19
• Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
• Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19
• Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
• A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
• Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
• Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
• Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
• STerOids in COVID-19 Study
• PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS
• Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
• Tofacitinib for Treatment of Moderate COVID-19
• SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival
• Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19
• Ruxolitinib in the Treatment of Covid-19
• Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection
• Cyclosporine in Patients With Moderate COVID-19
• Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS
• Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study
• Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
• Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
• An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19
• Study of Sargramostim in Patients With COVID-19
• Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
• A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
• Cholecalciferol to Improve the Outcomes of COVID-19 Patients
• Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
• Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum
• P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
• Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19
• Aggrenox To Treat Acute Covid-19
• Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients
• DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
• Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
• Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients
• Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
• Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger
• Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
• Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
• High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy
• GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
• InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
• Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms
• Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.
• Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
• Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
• Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
• Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)
• The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
• TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)
• COVID-19 Ozanimod Intervention Study
• PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
• COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial
• Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"
• Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
• LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
• TD-0903 for ALI Associated With COVID-19
• Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
• Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
• TXA127 for the Treatment of Severe COVID-19
• Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
• Lessening Organ Dysfunction With VITamin C - COVID-19
• Using GM-CSF as a Host Directed Therapeutic Against COVID-19
• Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19
• Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
• Niclosamide for Mild to Moderate COVID-19
• iNOPulse for COVID-19
• Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
• Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
• A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19
• Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
• Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
• COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada
• Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting
• Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
• International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
• A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
• Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.
• Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial
• Hydroxychloroquine in COVID-19 Patients
• Trial of Imatinib for Hospitalized Adults With COVID-19
• Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
• Silymarin in COVID-19 Pneumonia
• Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
• Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
• SINUS WASH Pilot Study in Adults Testing Positive for COVID-19
• Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients
• mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms
• Baricitinib Compared to Standard Therapy in Patients With COVID-19
• ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19
• Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
• New Antiviral Drugs for Treatment of COVID-19
• A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
• Colchicine Plus Phenolic Monoterpenes to Treat COVID-19
• Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)
• COVID-19 and Anti-CD14 Treatment Trial
• Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
• Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
• Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)
• Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal
• mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
• LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia
• Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19
• TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
• Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
• Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection
• Convalescent Plasma for the Treatment of COVID-19
• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
• The COvid-19 Symptom MOntelukast Trial
• PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
• Interferon Lambda Therapy for COVID-19
• Inhaled Nitric Oxide for Preventing Progression in COVID-19
• Favipiravir vs Hydroxychloroquine vs Control in COVID -19
• Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
• Oral 25-hydroxyvitamin D3 and COVID-19
• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia
• Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
• Study on the Use of Sarilumab in Patients With COVID-19 Infection
• Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
• Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
• #StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19
• Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
• Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection
• Hyperimmune Plasma in Patients With COVID-19 Severe Infection
• Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19
• Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19
• Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
• High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)
• Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure
• Study of Efficacy and Safety of MAS825 in Patients With COVID-19
• Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants
• Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19
• Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
• A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
• A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy
• A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)
• Randomised Evaluation of COVID-19 Therapy
• Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19
• Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia
• Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19
• Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
• Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
• Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
• Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
• Atorvastatin as Adjunctive Therapy in COVID-19
• Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
• Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
• A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
• Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
• A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)
• InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort
• A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes
• CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
• Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
• The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
• A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients
• Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
• A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
• Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
• Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
• Fluoxetine to Reduce Intubation and Death After COVID19 Infection
• Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19
• Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease
• PET/CT Imaging in COVID-19 Patients
• London's Exogenous Surfactant Study for COVID19
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
• Colchicine in COVID-19: a Pilot Study
• Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
• Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
• The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
• Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
• Asymptomatic COVID-19 Trial
• Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
• Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
• A Study of N-acetylcysteine in Patients With COVID-19 Infection
• Trial to Promote Recovery From COVID-19 With Endocrine Therapy
• Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS
• Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection
• Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study
• Early Intervention in COVID-19: Favipiravir Verses Standard Care
• Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
• Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.
• Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
• Duvelisib to Combat COVID-19
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
• Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19
• Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
• Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19
• DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)
• Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk
• Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients
• Sirolimus in COVID-19 Phase 1
• Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019
• Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients
• Proactive Care of Ambulatory COVID19 Patients
• Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
• Clinical Application of Methylene Blue for Treatment of Covid-19 Patients
• Multi-site Adaptive Trials for COVID-19
• INB03 for the Treatment of Pulmonary Complications From COVID-19
• Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.
• Treating COVID-19 With Hydroxychloroquine (TEACH)
• A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
• Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients
• Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
• Repurposing of Chlorpromazine in Covid-19 Treatment
• Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19
• Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
• Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
• Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
• Ramipril for the Treatment of COVID-19
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
• Cardiovascular Effects of COVID-19
• OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome
• The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
• Protective Effect of Aspirin on COVID-19 Patients
• Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)
• Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial
• Canakinumab in Covid-19 Cardiac Injury (The Three C Study)
• Progesterone for the Treatment of COVID-19 in Hospitalized Men
• The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial
• COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients
• A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)
• Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland
• Anakinra for COVID-19 Respiratory Symptoms
• Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)
• The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
• Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia
• Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
• A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19
• Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
• Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment
• VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
• Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
• Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm
• Early Treatment of Cytokine Storm Syndrome in Covid-19
• Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
• Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial
• Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)
• Isotretinoin in Treatment of COVID-19
• Leflunomide in Mild COVID-19 Patients
• Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
• The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection
• Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial
• Covid-19 Associated Coagulopathy
• Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19
• Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
• Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
• Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19
• Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
• Nebulised Dornase Alfa for Treatment of COVID-19
• Favipiravir in Hospitalized COVID-19 Patients
• Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
• Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
• Estrogen Patch for COVID-19 Symptoms
• Azithromycin in Hospitalized COVID-19 Patients
• Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
• Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
• Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
• Baricitinib Therapy in COVID-19
• Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
• Rhu-pGSN for Severe Covid-19 Pneumonia
• Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
• Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19
• Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)
• Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
• Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia
• Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
• suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
• Measles Vaccine in HCW
• Etoposide in Patients With COVID-19 Infection
• Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
• COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
• Sevoflurane in COVID-19 ARDS (SevCov)
• Telmisartan for Treatment of COVID-19 Patients
• Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19
• Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)
• Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
• Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm
• Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)
• Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus
• Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
• COVID-19 PrEP HCW HCQ Study
• Administration of Chlorpromazine as a Treatment for COVID-19
• Ruxolitinib to Combat COVID-19
• Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients
• Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
• Treatment for COVID-19 in High-Risk Adult Outpatients
• DAS181 for STOP COVID-19
• Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19
• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
• Stopping ACE-inhibitors in COVID-19
• Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
• Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
• Camostat Mesylate in COVID-19 Outpatients
• Trial of Hydroxychloroquine In Covid-19 Kinetics
• Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)
• Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.
• HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial
• PROLIFIC ChemoprophylaxisTrial (COVID-19)
• Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients
• Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)
• Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
• Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms
• Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
• High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19
• Test and Treat COVID 65plus+
• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
• PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19
• First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
• Umifenovir in Hospitalized COVID-19 Patients
• Interferon Beta 1a in Hospitalized COVID-19 Patients
• Dapagliflozin in Respiratory Failure in Patients With COVID-19
• Polyvalent Immunoglobulin in COVID-19 Related ARds
• Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
• Trial to Study the Benefit of Colchicine in Patients With COVID-19
• Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection
• Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19
• The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
• Efficacy and Safety of Favipiravir in Management of COVID-19
• Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection
• Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
• Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
• Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19
• Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19
• Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.
• Hydrocortisone for COVID-19 and Severe Hypoxia
• Safety and Efficacy of Ruxolitinib for COVID-19
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
• PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)
• The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19
• Preventing COVID-19 in Healthcare Workers With HCQ: A RCT
• EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
• Honey & Nigella Sativa Trial Against COVID-19
• Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
• Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
• A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients
• CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort
• Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
• Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
• Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen
• Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients
• Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
• Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
• Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
• Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
• A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
• Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers
• A Study of Auxora in Patients With Severe COVID-19 Pneumonia
• Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients
• Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression
• Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
• Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
• Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
• Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
• Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia
• Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection
• Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
• Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
• Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
• Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
• Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19
• SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
• COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)
• A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Pegylated Interferon Lambda Treatment for COVID-19
• Pyridostigmine in Severe SARS-CoV-2 Infection
• An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)
• Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.
• Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
• Coronavirus Response - Active Support for Hospitalised Covid-19 Patients
• A Study of LY3127804 in Participants With COVID-19
• The Role of Resistant Starch in COVID-19 Infection
• A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection
• Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
• Hydroxychloroquine for COVID-19
• University of Utah COVID-19 Hydrochloroquine Trial
• Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19
• Effects of DPP4 Inhibition on COVID-19
• Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO
• Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
• A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients
• Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia
• CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection
• Will Hydroxychloroquine Impede or Prevent COVID-19
• Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
• Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury
• Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
• Hydroxychloroquine for the Treatment of Mild COVID-19 Disease
• Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals
• Safety and Efficacy of Baricitinib for COVID-19
• Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial
• Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
• Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
• Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation
• Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19
• Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED
• Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19
• Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
• Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients
• TXA and Corona Virus 2019 (COVID19) in Outpatients
• Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19
• HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers
• Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
• Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
• Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection
• Checkpoint Blockade in COVID-19 Pandemic
• Defibrotide in COVID-19 Pneumonia
• Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
• Study of Open Label Losartan in COVID-19
• A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
• Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
• EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)
• Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
• Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
• A Study of Quintuple Therapy to Treat COVID-19 Infection
• Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects
• Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19
• Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019
• Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine
• Treatment of SARS Caused by COVID-19 With Ruxolitinib
• Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection
• CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION
• Chloroquine for Mild Symptomatic and Asymptomatic COVID-19
• Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
• Application of Desferal to Treat COVID-19
• Piclidenoson for Treatment of COVID-19
• Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
• Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
• Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
• Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study
• Convalescent Plasma for Patients With COVID-19: A Pilot Study
• Azithromycin for COVID-19 Treatment in Outpatients Nationwide
• Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
• TOFAcitinib in SARS-CoV2 Pneumonia
• Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19
• Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic
• Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
• Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia
• Chloroquine as Antiviral Treatment in Coronavirus Infection 2020
• Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
• Protective Role of Inhaled Steroids for Covid-19 Infection
• Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
• Treatment of COVID-19 Patients With Anti-interleukin Drugs
• A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19
• Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection
• Coronavirus (COVID-19) ACEi/ARB Investigation
• Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)
• The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
• Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19
• Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
• ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19
• ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
• The Vietnam Chloroquine Treatment on COVID-19
• The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.
• Pre-exposure Prophylaxis for SARS-Coronavirus-2
• Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
• Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers
• Effectiveness of Hydroxychloroquine in Covid-19 Patients
• COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19
• Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
• COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
• BCG Vaccination to Protect Healthcare Workers Against COVID-19
• Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
• The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention
• ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
• Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection
• Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
• A Study of a Candidate COVID-19 Vaccine (COV001)
• DAS181 for Severe COVID-19: Compassionate Use
• Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial
• Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
• Traditional Chinese Medicine for Severe COVID-19
• Colchicine Counteracting Inflammation in COVID-19 Pneumonia
• Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
• The Impact of Camostat Mesilate on COVID-19 Infection
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
• Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
• Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
• Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia
• Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
• Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)
• Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
• CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)
• Norwegian Coronavirus Disease 2019 Study
• Trial of Treatments for COVID-19 in Hospitalized Adults
• Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)
• Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
• The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
• The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
• Losartan for Patients With COVID-19 Requiring Hospitalization
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
• Losartan for Patients With COVID-19 Not Requiring Hospitalization
• Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
• Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
• Tetrandrine Tablets Used in the Treatment of COVID-19
• Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT
• A Pilot Study of Sildenafil in COVID-19
• Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention
• Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting
• Fight COVID-19 Trial
• DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
• Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
• The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
• The Clinical Study of Carrimycin on Treatment Patients With COVID-19
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
• A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
• Adaptive COVID-19 Treatment Trial (ACTT)
• Fingolimod in COVID-19
• Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu
• Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
• Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
• Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
• Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
• Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia
• Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
• Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19
• The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19
• The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia
• Efficacy and Safety of Corticosteroids in COVID-19
• Immunoregulatory Therapy for 2019-nCoV
• Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
• The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
• Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection
• Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
• The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
• A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
• Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
• A Trial of Remdesivir in Adults With Severe COVID-19
• A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
• A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
• The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
• A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
• Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
• Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
• Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19
• Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
• Lessening Organ Dysfunction With VITamin C
• Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS
• The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
• Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia